CCF642
目录号: A16122
PDI 抑制剂
CCF642 是一种新型的 PDI 抑制剂,具有抗骨髓瘤活性。
Discription | CCF642 is a novel PDI-inhibiting compound with antimyeloma activity. | ||
---|---|---|---|
Targets |
|
目录号 | A16122 |
---|---|
分子式 | C15H10N2O4S3 |
分子量 | 378.45 |
CAS号 | 346640-08-2 |
SMILES | COC1=CC=C(C=C1)N2C(=O)C(=CC3=CC=C(S3)[N+](=O)[O-])SC2=S |
其他名称 | CCF 642, CCF-642 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 14 mg/mL (36.99 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 26.42 mL | 132.12 mL | 264.24 mL |
0.5 mM | 5.28 mL | 26.42 mL | 52.85 mL |
1 mM | 2.64 mL | 13.21 mL | 26.42 mL |
5 mM | 0.53 mL | 2.64 mL | 5.28 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2